Eurobio Scientific Société anonyme (EPA:ALERS)
23.90
+0.15 (0.63%)
At close: Jan 30, 2026
EPA:ALERS Revenue
Eurobio Scientific Société anonyme had revenue of 80.80M EUR in the half year ending June 30, 2025, with 36.09% growth. This brings the company's revenue in the last twelve months to 162.47M, up 12.40% year-over-year. In the year 2024, Eurobio Scientific Société anonyme had annual revenue of 154.95M with 18.60% growth.
Revenue (ttm)
162.47M
Revenue Growth
+12.40%
P/S Ratio
1.48
Revenue / Employee
427.56K
Employees
380
Market Cap
240.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 154.95M | 24.30M | 18.60% |
| Dec 31, 2023 | 130.65M | -22.25M | -14.55% |
| Dec 31, 2022 | 152.90M | -32.42M | -17.49% |
| Dec 31, 2021 | 185.32M | -3.87M | -2.04% |
| Dec 31, 2020 | 189.19M | 129.71M | 218.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 820.92M |
| Biosynex | 97.95M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.38M |
| Novacyt | 22.69M |
| Implanet | 11.10M |
| Mauna Kea Technologies | 8.18M |
| Affluent Medical | 5.27M |